One-year safety and efficacy of budesonide/formoterol in a single inhaler (Symbicort® Turbuhaler®) for the treatment of asthma

This publication has 14 references indexed in Scilit:

• Low Dose Inhaled Budesonide and Formoterol in Mild Persistent Asthma
  American Journal of Respiratory and Critical Care Medicine, 2001
• Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone
  European Respiratory Journal, 2001
• Adding formoterol to budesonide in moderate asthma—health economic results from the FACET study
  Respiratory Medicine, 2001
• Oxis®(formoterol given by Turbuhaler®) showed as rapid an onset of action as salbutamol given by a pMDI
  Respiratory Medicine, 2000
• Asthma quality of life during 1 year of treatment with budesonide with or without formoterol
  European Respiratory Journal, 1999
• Development and validation of a questionnaire to measure asthma control
  European Respiratory Journal, 1999
• Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
  New England Journal of Medicine, 1997
• Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency
  European Respiratory Journal, 1997
• Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
  American Journal of Respiratory and Critical Care Medicine, 1996
• Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
  The Lancet, 1994